HORIZON FLEXIBLE INCOME ETF (FLXN) Stock News

NYSEARCA:FLXN - US44053A5231 - ETF

25.37 USD

+0.02 (+0.08%)

Last: 8/28/2025, 8:10:23 PM

Technical Analysis

FLXN Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Benzinga - Mentions: SFTY DIVN STOX BNDY

Horizon Expands ETF Lineup With 2 Funds For Smarter Bond Income And Volatility Defense

2 months ago - By: Horizon - Mentions: BNDY

Horizon Continues to Build Its Lineup of Exchange Traded Funds with the Launch of Two New Active Fixed Income ETFs

4 years ago - By: Halper Sadeh LLP - Mentions: ECHO HRC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ECHO, ACBI, HRC, FLXN; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Benzinga

Analyst Ratings For Flexion Therapeutics

4 years ago - By: The Business Journals - Mentions: PCRX

News Image

Flexion skyrockets on news of $500M acquisition

4 years ago - By: Zacks Investment Research - Mentions: ENDP PCRX ENTA

Pacira's (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark

4 years ago - By: Zacks Investment Research

Earnings Preview: Flexion Therapeutics (FLXN) Q3 Earnings Expected to Decline

4 years ago - By: Zacks Investment Research - Mentions: PCRX ARDX GMTX

Flexion (FLXN) to Report Q3 Earnings: What's in the Cards?

4 years ago - By: Kahn Swick & Foti, LLC

FLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN

4 years ago - By: WeissLaw LLP - Mentions: PCRX

SHAREHOLDER ALERT: WeissLaw LLP Investigates Flexion Therapeutics, Inc.

4 years ago - By: Rowley Law PLLC - Mentions: PCRX

News Image

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Flexion Therapeutics, Inc.

4 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained a Fair Price in its transaction with Pacira

4 years ago - By: InvestorPlace

FLXN Stock Is Winning Big Today Ahead of Merger With Pacira

4 years ago - By: Halper Sadeh LLP

Flexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLXN